LanzaTech Global, Inc. (NASDAQ:LNZA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

LanzaTech Global, Inc. (NASDAQ:LNZA - Get Free Report) has earned an average rating of "Moderate Buy" from the four brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $6.33.

Separately, TD Cowen decreased their price target on shares of LanzaTech Global from $3.00 to $2.00 and set a "hold" rating for the company in a report on Monday.

LanzaTech Global Stock Down 7.4 %

NASDAQ:LNZA traded down $0.13 during mid-day trading on Monday, reaching $1.58. The stock had a trading volume of 280,332 shares, compared to its average volume of 436,008. The stock's 50 day simple moving average is $1.73 and its two-hundred day simple moving average is $1.93. LanzaTech Global has a 1-year low of $1.16 and a 1-year high of $5.73. The company has a market capitalization of $311.48 million, a price-to-earnings ratio of -2.39 and a beta of 1.58. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.40 and a quick ratio of 4.40.

LanzaTech Global (NASDAQ:LNZA - Get Free Report) last announced its quarterly earnings results on Friday, November 8th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by ($0.16). LanzaTech Global had a negative return on equity of 96.75% and a negative net margin of 143.76%. The business had revenue of $9.94 million for the quarter, compared to analyst estimates of $17.87 million. During the same quarter last year, the firm posted ($0.13) EPS. Equities analysts anticipate that LanzaTech Global will post -0.48 EPS for the current year.

Institutional Trading of LanzaTech Global

A number of institutional investors have recently bought and sold shares of the business. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of LanzaTech Global by 14.4% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 207,940 shares of the company's stock valued at $644,000 after acquiring an additional 26,097 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of LanzaTech Global by 433.7% during the second quarter. Bank of New York Mellon Corp now owns 312,021 shares of the company's stock worth $577,000 after purchasing an additional 253,562 shares in the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in shares of LanzaTech Global in the 2nd quarter valued at $251,000. Principal Financial Group Inc. bought a new stake in shares of LanzaTech Global in the 2nd quarter valued at $28,000. Finally, XTX Topco Ltd bought a new stake in shares of LanzaTech Global in the 2nd quarter valued at $26,000. Institutional investors and hedge funds own 17.76% of the company's stock.

About LanzaTech Global

LanzaTech Global, Inc operates as a nature-based carbon refining company in the United States and internationally. The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging. It is also developing biocatalysts and processes to produce a suite of additional products utilizing novel biocatalysts, including acetone and isopropanol (IPA) and industrial solvents used in various applications, including production of polymers from IPA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.